KRW 28400.0
(1.79%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 537.28 Billion KRW | 13.68% |
2022 | 472.62 Billion KRW | 8.18% |
2021 | 436.89 Billion KRW | 4.9% |
2020 | 416.5 Billion KRW | 38.68% |
2019 | 300.34 Billion KRW | 19.48% |
2018 | 251.37 Billion KRW | 16.38% |
2017 | 216 Billion KRW | 20.44% |
2016 | 179.34 Billion KRW | 0.0% |
2014 | 254.51 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 542.82 Billion KRW | 1.03% |
2024 Q2 | 566.21 Billion KRW | 4.31% |
2023 Q4 | 537.28 Billion KRW | 8.07% |
2023 FY | 537.28 Billion KRW | 13.68% |
2023 Q1 | 469.95 Billion KRW | -0.57% |
2023 Q2 | 473.5 Billion KRW | 0.76% |
2023 Q3 | 497.15 Billion KRW | 4.99% |
2022 Q2 | 471.28 Billion KRW | 7.03% |
2022 Q1 | 440.33 Billion KRW | 0.79% |
2022 FY | 472.62 Billion KRW | 8.18% |
2022 Q4 | 472.62 Billion KRW | 1.0% |
2022 Q3 | 467.95 Billion KRW | -0.71% |
2021 Q2 | 406.98 Billion KRW | -5.61% |
2021 Q4 | 436.89 Billion KRW | 1.1% |
2021 Q1 | 431.16 Billion KRW | 3.52% |
2021 FY | 436.89 Billion KRW | 4.9% |
2021 Q3 | 432.12 Billion KRW | 6.18% |
2020 FY | 416.5 Billion KRW | 38.68% |
2020 Q4 | 416.5 Billion KRW | 17.11% |
2020 Q3 | 355.66 Billion KRW | 2.53% |
2020 Q2 | 346.87 Billion KRW | 10.63% |
2020 Q1 | 313.55 Billion KRW | 4.4% |
2019 FY | 300.34 Billion KRW | 19.48% |
2019 Q1 | 260.58 Billion KRW | 3.66% |
2019 Q4 | 300.34 Billion KRW | 7.08% |
2019 Q3 | 280.49 Billion KRW | 6.13% |
2019 Q2 | 264.29 Billion KRW | 1.43% |
2018 FY | 251.37 Billion KRW | 16.38% |
2018 Q3 | 224.7 Billion KRW | 4.72% |
2018 Q2 | 214.57 Billion KRW | 1.73% |
2018 Q4 | 251.37 Billion KRW | 11.87% |
2018 Q1 | 210.93 Billion KRW | -2.35% |
2017 Q2 | 190.88 Billion KRW | 0.35% |
2017 Q4 | 216 Billion KRW | 6.09% |
2017 FY | 216 Billion KRW | 20.44% |
2017 Q1 | 190.22 Billion KRW | 6.07% |
2017 Q3 | 203.6 Billion KRW | 6.66% |
2016 Q3 | 172.39 Billion KRW | 0.0% |
2016 Q4 | 179.34 Billion KRW | 4.03% |
2016 FY | 179.34 Billion KRW | 0.0% |
2014 FY | 254.51 Billion KRW | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 141.35 Billion KRW | -280.106% |
CMG Pharmaceutical Co., Ltd. | 186.85 Billion KRW | -187.546% |
Celltrion Pharm, Inc. | 641.64 Billion KRW | 16.264% |
Huons Global Co., Ltd. | 1317.96 Billion KRW | 59.234% |
DongKook Pharmaceutical Co., Ltd. | 839.53 Billion KRW | 36.002% |
Enzychem Lifesciences Corporation | 211.54 Billion KRW | -153.981% |
Humedix Co., Ltd. | 219.97 Billion KRW | -144.245% |
Boditech Med Inc. | 227.9 Billion KRW | -135.753% |
EuBiologics Co., Ltd. | 172.64 Billion KRW | -211.214% |
FutureChem Co.,Ltd | 72.83 Billion KRW | -637.693% |
BNC Korea Co., Ltd. | 236.15 Billion KRW | -127.516% |
AptaBio Therapeutics Inc. | 92.51 Billion KRW | -480.729% |